Keyphrases
Risk Ratio
100%
Hepatic Encephalopathy
100%
Confidence Interval
100%
Cirrhosis
100%
Serious Adverse Events
50%
Beneficial Effects
35%
Event Risk
30%
Placebo
30%
Risk of Bias
25%
Low Risk
25%
Randomized Clinical Trial
20%
Non-serious
15%
Mortality Risk
15%
Subgroup Analysis
10%
Cochrane
10%
Covert Hepatic Encephalopathy
10%
Active Agent
10%
Meta-analysis
10%
Hepatobiliary
10%
Pharmaceutical Companies
10%
Clinical Analysis
10%
Ammonia
10%
Branched-chain Amino Acids
5%
Intravenous Administration
5%
Embase
5%
Review Authors
5%
Blood Ammonia
5%
Publication Status
5%
Associated Morbidity
5%
Randomized Placebo-controlled Trial
5%
Ammonia Concentration
5%
Cirrhosis Complications
5%
Double-blind Clinical Trial
5%
Active Intervention
5%
MEDLINE
5%
Sensitivity Analysis
5%
Conference Proceedings
5%
Psychometric Testing
5%
Inclusion Criteria
5%
Science Citation Index Expanded
5%
Health-related Quality of Life
5%
Antibiotics
5%
Search Methods
5%
Regression Analysis
5%
Absence of Evidence
5%
Selection Criteria
5%
Overall Assessment
5%
Other-benefit
5%
Harmful Effects
5%
Small Clinical Trials
5%
Access to Data
5%
Potential Gains
5%
Bias Control
5%
Publication Bias
5%
Manual Search
5%
Lactulose
5%
Common Complications
5%
Baseline Risk
5%
Electronic Search
5%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cirrhosis
100%
Hepatic Encephalopathy
100%
Aspartic Acid
100%
Ornithine
100%
Adverse Event
66%
Placebo
46%
Randomized Clinical Trial
26%
Branched Chain Amino Acid
6%
Antibiotics
6%
Lactulose
6%
Syndrome
6%
Clinical Trial
6%
Disaccharide
6%
Rifaximin
6%
Neuroscience
Hepatic Encephalopathy
100%
Ornithine
100%
Aspartic Acid
100%
Placebo
46%
Meta-Analysis
13%
Branched-Chain Amino Acid
6%
Disaccharide
6%
Lactulose
6%